Page 104 - ARNM-3-2

Advances in Radiotherapy
& Nuclear Medicine A dosimetric research on iodine-125 seed implantation

Acknowledgments doi: 10.3760/cma.j.issn.1673-4114.2019.03.006

None. 4. Li Bo, De Mei C. Study on the value of 125I radioactive
seed implantation in the treatment of recurrent and
Funding metastatic lesions of lung cancer. J Imaging Res Med Appl.
2024;8(15):176-178.
This study was funded by the Research Fund Project of
Hebei Provincial Health and Family Planning Commission doi: 10.3969/j.issn.2096-3807.2024.15.056
(20242265). 5. Guohui C, Juan W, Zeyang W, et al. Clinical efficacy and
influencing factors of 125I seeds implantation in the
Conflict of interest treatment of patients with advanced lung cancer after
radiotherapy and chemotherapy. Chin J Nucl Med Mol
Hongtao Zhang is the Editorial Board Member of this Imaging. 2023;43(1):16-19.
journal but was not in any way involved in the editorial
and peer-review process conducted for this paper, directly doi: 10.3760/cma.j.cn321828-20210625-00210
or indirectly. Separately, other authors declared that they 6. Yuxuan C. Application of PET/CT image fusion in
have no known competing financial interests or personal precise delineation of three-dimensional conformal
relationships that could have influenced the work reported radiotherapy target area for NSCLC. J Med Theory Pract.
in this paper. 2022;35(8):1322-1324.
doi: 10.19381/j.issn.1001-7585.2022.08.023
Author contributions
7. Jinbo Y, Ye Z, Wencheng Z, et al. Chinese expert consensus
Conceptualization: Hongtao Zhang, Juan Wang on radiation therapy doctor’s evaluation of radiation therapy
Formal analysis: Ke Xu plan. Chin J Cancer Prev Treat. 2024;31(8):453-470.
Investigation: Jinxin Zhao, Zezhou Liu doi: 10.16073/j.cnki.cjcpt.2024.08.01
Methodology: Guohui Cao, Xiaoli Liu 8. Diamant A, Heng VJ, Chatterjee A, et al. Comparing local
Writing – original draft: Ke Xu control and distant metastasis in NSCLC patients between
Writing – review & editing: Xiaoli Liu, Ke Xu
cyberknife and conventional SBRT. Radiother Oncol.
Ethics approval and consent to participate 2020;144:201-208.
doi: 10.1016/j.radonc.2020.01.017
This study has been approved by the Ethics Committee
Application for Approval of Research Protocol, Hebei 9. Min F, Xianghui D, Xiaojing L. Clinical application and
General Hospital (NO.2025-LW-0078). prospect of SBRT in treatment of oligo-metastatic NSCLC.
Chin J Radiat Oncol. 2023;32(7):633-637.
Consent for publication doi: 10.3760/cma.j.cn113030-20220725-00250

Not applicable. 10. Shi Y, Ma X, He D, Dong B, Qiao T. Neoadjuvant SBRT
combined with immunotherapy in NSCLC: From
Availability of data mechanisms to therapy. Front Immunol. 2023;14:1213222.
The original findings presented in this study are included doi: 10.3389/fimmu.2023.1213222
in the article/supplementary material. Further inquiries 11. International Commission on Radiation Units and Mea-
can be directed to the corresponding author. Surements. Prescribing, recording, and reporting photon-
beam intensity- modulated radiation therapy (IMRT).
References J ICRU. 2010;10(1):NP.
1. Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp 12. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response
Med Biol. 2016;893:1-19. evaluation criteria in solid tumors: Revised RECIST
doi: 10.1007/978-3-319-24223-1-1 guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247.
doi: 10.1016/j.ejca.2008.10.026
2. Yizong W. Clinical Application of Iodine-125 Seed
Implantation to Locally Advanced and Advanced Non-Small 13. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation
Cell Lung Cancer. Taiwan: Soochow University; 2016. therapy oncology group (RTOG) and the European
organization for research and treatment of cancer (EORTC).
125
3. Guo Y, Zhang Z, Huo X, Dong H. Effect of I implantation
on pulmonary function in impossible non-small cell lung Int J Radiat Oncol Biol Phys. 1995;31(5):1341-1346.
cancer. Int J Radiat Med Nucl Med. 2019;43(3):230-234. doi: 10.1016/0360-3016(95)00060-C

Volume 3 Issue 2 (2025) 96 doi: 10.36922/arnm.8512